PCI is a leading global CDMO, truly spanning the cycle, connecting development and commercialization, de-risking the supply chain providing clients with integrated end-to-end drug development, manufacturing, and packaging capabilities that increase their products’ speed to market and opportunities for commercial success.
PCI brings the proven experience that comes with more than 90 successful product launches each year and over five decades in the healthcare services business. Leading technology and continued investment enable us to address global outsourcing development needs throughout the product lifecycle.
PCIs offers a global network of innovative centers of excellence for the development, manufacturing, packaging, storage, and distribution of life-changing therapies. Our specialist-contained manufacturing and packaging facilities are dedicated to processing highly potent drug products combined with our renowned lyophilization and sterile manufacturing capabilities complemented by a global network of packaging sites. Our aim is simple, to accelerate your product from development to commercialization as efficiently and cost-effectively as possible.
Drug Development and Manufacturing Solutions
PCI are experts and innovators offering full-service formulation development including analytical development/characterization of sterile and non-sterile dosage forms. Our scalable development and manufacturing capabilities for tablets, capsules, gels, ointments, liquids, and lyophilized drug products aid the delivery of life-changing therapies to patients from early-phase clinical trials through to commercialization.
Clinical Trial Services
PCI provides a global service with a localized focus, delivering over 200 protocols a year in over 100 countries, utilizing best-in-class technologies combined with our experienced and dedicated teams. Providing a seamless clinical service PCI supports the global supply of investigational medicines with pharmaceutical development, clinical drug product manufacturing, packaging, labeling, storage and distribution.
Commercial Packaging Technology
With true customer focus and flexibility at the core of our commercial pharmaceutical packaging, we are able to support the unique requirements of each product type and global market supplied. Utilizing state-of-the-art packaging technologies we provide advanced primary, secondary, and tertiary packaging solutions for a diverse portfolio of conventional dosage forms including oral solids, powders, liquids, creams, and gels, as well as specialist injectable and parenteral delivery forms including vials, cartridges, prefilled syringes, and auto-injectors.
PCI is a strategic partner and an integral part of the supply chain as the bridge between life-changing therapies and patients of our global customer base. Our expertise combined with market-leading technologies means we deliver more than just a service, we are a trusted partner sharing an industry-leading depth and breadth of knowledge.
Summary of our integrated end-to-end solutions to accelerate your product through development to commercialization include:
- Pharmaceutical development
- High-potent drug product manufacturing
- Sterile fill-finish
- Clinical trial services
- Commercial packaging and labeling
- Storage and distribution (controlled ambient, cold, frozen)
- More than 50 years of experience in the healthcare services business
- Operating from 30 GMP facilities across North America, Canada, Europe, the UK, and the Asia Pacific
- Over 4,300 employees work to bring life-changing therapies to patients
- Delivering over 200 protocols a year in over 100 countries
- Supporting more than 90 commercial product launches each year
PCI Pharma Services HQ
3001 Red Lion Road
T: +1 215 613 3600